QDDresearch

Ganfeng Lithium Group Co., Ltd GNENY

MaterialsChemicalsChina

Last close 2.85 USD on Nov 1, 2026, −58.0% year to date

Quant rating

Quant rating C Rank 130 of 220 in Materials
  1. Growth C 130 of 220
  2. Valuation A 31 of 220
  3. Quality B 43 of 220
  4. Revisions D 172 of 220
  5. Momentum D 195 of 220

Wall Street consensus Buy (2.11)Average target 8.91 USD +212.0%

Historical valuation

Multiples use consensus estimates for the next twelve months. The dashed line is the 5-year average.

Growth and profitability fiscal year ends December 31

Growth and profitability by fiscal year
202520242023202220215Y avg
Revenue (mil)3,3012,5904,6456,0641,757–
Revenue growth27.4%−44.2%−23.4%245.1%107.6%31.3%
EPS (basic, normalized)0.11−0.140.341.470.42–
EPS growth––−76.9%253.0%––
Gross margin14.4%8.9%8.9%49.4%39.8%24.3%
Net margin7.0%−11.0%15.0%49.0%46.8%21.4%
ROE3.7%−4.7%10.9%62.2%32.1%20.8%
Balance sheet, last quarter
Cash & short-term investments (mil)1,495
Current ratio1.09x
Long-term debt (mil)3,655
Net debt (mil)5,667
Total equity (mil)7,178
Net debt / equity0.79x
Net debt / EBITDA11.07x

Estimates and valuation

Consensus estimates and implied multiples
Sales (mil)EBITDA (mil)EPS
Fiscal yearMean est.GrowthEV/SalesMean est.GrowthEV/EBITDAMean est.GrowthP/E
2025 actual 3,301+27.4%4.7x 512+111.6%30.3x 0.11+180.6%25.0x
2026 6,750+104.5%2.3x 1,654+223.1%9.4x 0.45+292.9%6.4x
2027 7,082+4.9%2.2x 1,569−5.1%9.9x 0.44−1.3%6.4x
2028 7,855+10.9%2.0x 1,943+23.8%8.0x 0.58+31.9%4.9x

Estimate revisions

Change in consensus estimates over 1, 3 and 6 months
SalesEPS
Fiscal yearEstimate (mil)1M3M6MEstimate1M3M6M
20266,750−1.6%+2.3%+8.2%0.45−10.1%−9.7%+4.0%
20277,082−4.7%−3.6%+0.4%0.44−19.7%−16.2%−7.2%
20287,855−6.0%−6.4%−3.6%0.58−12.4%−16.3%−9.8%

Earnings surprises EPS beat in 1 of the last 4 quarters

Reported results versus consensus, last 10 fiscal quarters
Quarter endedJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales reported (mil)4,5314,3364,9813,7724,6046,2498,4579,19613,90213,062
Sales mean (mil)9,2914,7996,3354,973––6,131–18,85916,282
Surprise−51.2%−9.6%−21.4%−24.2%––+37.9%–−26.3%−19.8%
EPS reported−0.160.06−0.71−0.18−0.090.280.780.881.150.36
EPS mean0.330.300.200.10−0.150.180.17–1.340.72
Surprise−148.5%−80.0%−455.0%−280.0%+40.0%+55.6%+358.8%–−14.3%−49.4%

Peer comparison Chemicals

Peers in the same industry group, by market capitalization
CompanyMarket capNet debt/EBITDANet marginP/BFY1 P/EFY2 P/EFY1 EV/EBITDAFY2 EV/EBITDA
GNENY Ganfeng Lithium Group Co., Ltd9.8B11.07x7.0%1.52x6.4x6.4x9.4x9.9x
YARIY Yara International ASA10.9B–––8.5x10.2x3.5x3.8x
ALB Albemarle Corp10.7B2.49x−13.2%1.04x8.1x8.9x5.0x5.1x
MTLHY Mitsubishi Chemical Group Corporation10.7B3.69x−2.2%0.87x48.8x47.6x5.9x5.8x
BNTGY Brenntag SE10.2B2.41x1.7%2.06x3.2x3.2x8.5x8.7x
SOLS Solstice Advanced Materials Inc9.6B1.68x6.1%6.06x20.9x17.7x10.8x9.8x
Mean4.27x−0.1%2.31x16.0x15.7x7.2x7.2x
Median2.49x1.7%1.52x8.3x9.6x7.2x7.2x

Technical analysis

  • 1M−24.1%
  • 3M−38.3%
  • 1Y−55.3%
  • 3Y−25.5%

Financial statements in millions of USD

Income statement, Ganfeng Lithium Group Co., Ltd, fiscal years, most recent first
202520242023202220212020
Total revenue3,3012,5904,6456,0641,757847
Cost of revenue2,8252,3604,2313,0701,058666
Gross profit4762304142,994699181
Selling, general & administrative expenses21714517520890.437.2
Research & development13711617114149.019.0
Depreciation/amortization29.123.015.111.410.57.1
Interest expense (income), operating166304−448−654−337−59.8
Unusual expense (income)−20111.7−23.73.3−3.616.7
Other operating expenses−40.0−53.9−210−14.4−8.8−12.0
Operating income168−3167343,298899173
Net interest income (expense)––––––
Gain (loss) on sale of assets––––––
Other non-operating income (expense)2.00.46.74.59.9−0.2
Net income before taxes170−3157413,303909173
Provision for taxes−10.745.196.333656.29.8
Minority interest50.176.252.36.2−29.6−6.0
Equity in affiliates––––––
U.S. GAAP adjustment––––––
Net income before extraordinary items231−2846972,973823157
Extraordinary items––––––
Net income231−2846972,973823157
EBIT, normalized133−0.12632,647558130
EBITDA, normalized4341763862,720616171
Basic EPS, normalized0.11−0.140.341.470.42–

Disclaimer

The financial data presented in this report is delayed and obtained from sources QDD Research believes to be reliable, including stock exchanges, SEDAR, and EDGAR. However, no representation or warranty is made as to the accuracy, completeness, or timeliness of the information. QDD Research accepts no liability for any errors, omissions, or financial losses arising from the use of this data.

This report is generated using a fully systematic and quantitative approach. All factor scores and the overall quant rating (ranging from D to A+) are derived from algorithmic models and are based solely on objective financial metrics. These scores are intended for informational purposes only and should not be interpreted as investment advice or a recommendation to buy, sell, or hold any securities.

QDD Research is not a registered investment advisor or broker-dealer and does not provide personalized financial advice. The content is not tailored to the specific investment goals, financial situation, or risk profile of any individual investor. We strongly encourage readers to consult with a licensed broker or investment advisor before making any investment decisions based on the information contained in this report.

Live quote provided by TradingView. Report data updated Nov 1, 2026 after market close.